Literature DB >> 11470961

Recent advances in hereditary spastic paraplegia.

C M Tallaksen1, A Dürr, A Brice.   

Abstract

The hereditary spastic paraplegias are a group of rare disorders that are characterized by great clinical and genetic heterogeneity. There has been an exponential increase in the number of HSP loci mapped in recent years, with nine out of the 17 loci reported during the past 2 years. Eight loci have now been identified for the autosomal-dominant form, and seven of these are associated with pure HSP. Spastic paraplegia-4 remains the most frequent locus, and is usually associated with a pure phenotype. Although the corresponding spastin gene was only recently identified, over 50 mutations have been described to date, which renders molecular diagnosis difficult. Five loci are known for autosomal-recessive HSP, and four of these are associated with complex forms, all with different phenotypes. Two genes have been identified: paraplegin and sacsin. Finally, three loci have been identified in X-linked HSP, two of which are complex forms. The genes that encode L1 and PLP were the first to be identified in HSP disorders. Surprisingly, the five genes encode proteins of different families, making understanding and diagnosis of HSP even more difficult. The discovery of new genes should hopefully help to clarify the pathophysiology of these disorders.

Entities:  

Mesh:

Year:  2001        PMID: 11470961     DOI: 10.1097/00019052-200108000-00005

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  12 in total

1.  A novel locus for autosomal recessive spastic ataxia on chromosome 17p.

Authors:  Naima Bouslam; Ahmed Bouhouche; Ali Benomar; Sylvain Hanein; Stephan Klebe; Hamid Azzedine; Silvia Di Giandomenico; Anne Boland-Augé; Filippo M Santorelli; Alexandra Durr; Alexis Brice; Mohamed Yahyaoui; Giovanni Stevanin
Journal:  Hum Genet       Date:  2007-02-02       Impact factor: 4.132

2.  A locus for autosomal dominant hereditary spastic ataxia, SAX1, maps to chromosome 12p13.

Authors:  I A Meijer; C K Hand; K K Grewal; M G Stefanelli; E J Ives; G A Rouleau
Journal:  Am J Hum Genet       Date:  2001-12-31       Impact factor: 11.025

3.  Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60.

Authors:  Jens Jacob Hansen; Alexandra Dürr; Isabelle Cournu-Rebeix; Costa Georgopoulos; Debbie Ang; Marit Nyholm Nielsen; Claire-Sophie Davoine; Alexis Brice; Bertrand Fontaine; Niels Gregersen; Peter Bross
Journal:  Am J Hum Genet       Date:  2002-03-15       Impact factor: 11.025

4.  SPG11: a consistent clinical phenotype in a family with homozygous spatacsin truncating mutation.

Authors:  Roberto Del Bo; Alessio Di Fonzo; Serena Ghezzi; Federica Locatelli; Giovanni Stevanin; Antonella Costa; Stefania Corti; Nereo Bresolin; Giacomo Pietro Comi
Journal:  Neurogenetics       Date:  2007-08-24       Impact factor: 2.660

5.  Unique spectrum of SPAST variants in Estonian HSP patients: presence of benign missense changes but lack of exonic rearrangements.

Authors:  Mark Braschinsky; Riin Tamm; Christian Beetz; Elena Sachez-Ferrero; Elve Raukas; Siiri-Merike Lüüs; Katrin Gross-Paju; Catherine Boillot; Federico Canzian; Andres Metspalu; Sulev Haldre
Journal:  BMC Neurol       Date:  2010-03-09       Impact factor: 2.474

6.  Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia.

Authors:  Christelle Tesson; Magdalena Nawara; Mustafa A M Salih; Rodrigue Rossignol; Maha S Zaki; Mohammed Al Balwi; Rebecca Schule; Cyril Mignot; Emilie Obre; Ahmed Bouhouche; Filippo M Santorelli; Christelle M Durand; Andrés Caballero Oteyza; Khalid H El-Hachimi; Abdulmajeed Al Drees; Naima Bouslam; Foudil Lamari; Salah A Elmalik; Mohammad M Kabiraj; Mohammed Z Seidahmed; Typhaine Esteves; Marion Gaussen; Marie-Lorraine Monin; Gabor Gyapay; Doris Lechner; Michael Gonzalez; Christel Depienne; Fanny Mochel; Julie Lavie; Ludger Schols; Didier Lacombe; Mohamed Yahyaoui; Ibrahim Al Abdulkareem; Stephan Zuchner; Atsushi Yamashita; Ali Benomar; Cyril Goizet; Alexandra Durr; Joseph G Gleeson; Frederic Darios; Alexis Brice; Giovanni Stevanin
Journal:  Am J Hum Genet       Date:  2012-11-21       Impact factor: 11.025

7.  A novel locus for autosomal dominant "uncomplicated" hereditary spastic paraplegia maps to chromosome 8p21.1-q13.3.

Authors:  Sylvain Hanein; Alexandra Dürr; Pascale Ribai; Sylvie Forlani; Anne-Louise Leutenegger; Isabelle Nelson; Marie-Claude Babron; Nizar Elleuch; Christel Depienne; Céline Charon; Alexis Brice; Giovanni Stevanin
Journal:  Hum Genet       Date:  2007-06-28       Impact factor: 4.132

8.  Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia.

Authors:  Typhaine Esteves; Alexandra Durr; Emeline Mundwiller; José L Loureiro; Maxime Boutry; Michael A Gonzalez; Julie Gauthier; Khalid H El-Hachimi; Christel Depienne; Marie-Paule Muriel; Rafael F Acosta Lebrigio; Marion Gaussen; Anne Noreau; Fiorella Speziani; Alexandre Dionne-Laporte; Jean-François Deleuze; Patrick Dion; Paula Coutinho; Guy A Rouleau; Stephan Zuchner; Alexis Brice; Giovanni Stevanin; Frédéric Darios
Journal:  Am J Hum Genet       Date:  2014-01-02       Impact factor: 11.025

9.  Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia.

Authors:  Victoria Alvarez; Elena Sánchez-Ferrero; Christian Beetz; Marta Díaz; Belén Alonso; Ana I Corao; Josep Gámez; Jesús Esteban; Juan F Gonzalo; Samuel I Pascual-Pascual; Adolfo López de Munain; Germán Moris; Renne Ribacoba; Celedonio Márquez; Jordi Rosell; Rosario Marín; Maria J García-Barcina; Emilia Del Castillo; Carmen Benito; Eliecer Coto
Journal:  BMC Neurol       Date:  2010-10-08       Impact factor: 2.474

10.  The high prevalence of hereditary spastic paraplegia in Sardinia, insular Italy.

Authors:  Loretta Racis; Alessandra Tessa; Roberto Di Fabio; Eugenia Storti; Virgilio Agnetti; Carlo Casali; Filippo M Santorelli; Maura Pugliatti
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.